End-of-day quote
Other stock markets
|
||
- USD | - |
05-09 | UBS Adjusts Price Target on Madrigal Pharmaceuticals to $411 From $410, Maintains Buy Rating | MT |
05-07 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
- Stock Market
- Equities
- MDGL Stock
- Stock
- News Synta Pharmaceuticals Corp.
- Other languages